Last updated on May 2017

EAY131: Molecular Analysis for Therapy Choice (MATCH)


Brief description of study

EAY131: Molecular Analysis for Therapy Choice (MATCH)

Detailed Study Description

Solid tumor, lymphoma or multiple myeloma with measurable disease and progression following at least 1st line treatment.

Clinical Study Identifier: TX149738

Contact Investigators or Research Sites near you

Start Over

Nurdan Ilgaz

Baptist Health Clinical Research Center & Lexington Cardiac Research Foundation
Lexington, KY USA
  Connect »